Results 211 to 220 of about 87,711 (271)

Description and Characteristics of Ocular Tumor Lysis Syndrome. [PDF]

Ocul Oncol Pathol
de Carlo Forest TE, Oliver SCN.
europepmc   +1 more source

Recurrent Genomic Alterations in BCRi‐Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow‐Up

American Journal of Hematology, Volume 101, Issue 7, Page 1516-1521, July 2026.
Jennifer A. Woyach, Relja Popovic, Emily L. Rossi, Sanjana Singh, Toshihiko Oki, Tanya S. Rosenberg, Chen Qian, Michael Moran, Zihuan Liu, Michelle Boyer, Jeffrey Jones, Richard R. Furman, William Wierda, Jason Gotlib, Stephen J. Schuster, Brenda Chyla, Matthew S. Davids   +16 more
wiley   +1 more source

Elranatamab in Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Emerging Perspectives

European Journal of Haematology, Volume 117, Issue 1, Page 42-54, July 2026.
ABSTRACT Relapsed and refractory multiple myeloma (RRMM) remains associated with poor outcomes, particularly in patients exposed or refractory to proteasome inhibitors, immunomodulatory agents, and anti‐CD38 monoclonal antibodies. Targeting B‐cell maturation antigen (BCMA) has emerged as an effective therapeutic strategy, prompting the development of ...
Maria Eugenia Alvaro, Enrica Antonia Martino, Santino Caserta, Mamdouh Skafi, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Ernesto Vigna, Fortunato Morabito, Massimo Gentile   +12 more
wiley   +1 more source

Spontaneous Tumor Lysis Syndrome in an Undifferentiated Uterine Sarcoma: A Case Report and Review of the Literature. [PDF]

Clin Case Rep
Valizadeh Z, Farshchi P.
europepmc   +1 more source

Venetoclax‐Integrated Conditioning Strategies Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Myeloid Neoplasms: A Scoping Review of Emerging Evidence

European Journal of Haematology, Volume 117, Issue 1, Page 117-131, July 2026.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) remains the only potentially curative therapy for many patients with high‐risk myeloid neoplasms, yet relapse and transplant‐related toxicity continue to limit durable benefit.
Mohammed Abdulgayoom, Amaal Gulied, Awni Alshurafa, Shehab F. Mohamed, Mohamed A. Yassin, Afraa Fadul   +5 more
wiley   +1 more source

Impact of early versus conventional kidney replacement therapy initiation in tumor lysis syndrome: a target trial emulation. [PDF]

Ann Intensive Care
Serre J, Mulier G, Boud'hors C, Lemerle M, Abdel-Nabey M, Orvain C, Chaba A, Biard L, Demiselle J, Zafrani L.   +9 more
europepmc   +1 more source

Serum Leptin Exacerbates Osteoarthritis by Promoting Subchondral Bone H‐Type Vessel Angiogenesis via Activation of the PI3K/AKT Pathway

Journal of Cellular and Molecular Medicine, Volume 30, Issue 13, July 2026.
ABSTRACT Osteoarthritis (OA) is a common degenerative joint disease closely associated with obesity. Adipokines secreted by adipose tissue play critical roles in disease progression. This study focuses on the adipokine leptin and investigates its relationship with knee osteoarthritis.
Ruifu Li, Zhao Xi, Shitong Luo, Jun Qin, Tao Liu, Jian Zhang   +5 more
wiley   +1 more source

Tumor Lysis Syndrome Following Endoscopic Retrograde Cholangiopancreatography With Stent Placement in a Patient With Cholangiocarcinoma: A Case Report. [PDF]

Cureus
Boutari RA, Hallal MM, Mallah FI.
europepmc   +1 more source

Sex‐specific hepatic effects of sweetened alcohol consumption and tannic acid intervention in adolescent rats

Physiological Reports, Volume 14, Issue 13, July 2026.
Abstract This study investigated the combined effects of alcohol and sugar, termed sweetened alcohol consumption (SAC), and tannic acid (TA) intervention on hepatic health in adolescent rats. Sixty‐four male and female 42‐day‐old Sprague–Dawley rats were assigned to control, TA (50 mg/kg), SAC (10% ethanol +20% fructose), or SAC+TA groups and treated ...
Toluwase E. Olanipekun, Oladiran I. Olateju, Monica Gomes, Ashmeetha Manilall, Kennedy H. Erlwanger   +4 more
wiley   +1 more source

Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen. [PDF]

Eur J Haematol
Rowe M, Babushok D, Carroll M, Carulli A, Frey N, Gill S, Hexner E, Hirsh R, Hossain N, Lai C, Loren A, Luger S, Maillard I, McCurdy S, Matthews A, Martin ME, Paralkar VR, Perl A, Porter D, Pratz K, Stadtmauer E, Bruno XJ.   +21 more
europepmc   +1 more source